Glocalization Nature of Covid-19 Pandemic: The Nigerian Experience

COVID-19 has come as a global phenomenon with some globally agreed guidelines to curtail the pandemic, yet the approaches in each nation, localities, and communities differ, in order to embrace the peculiarities of local needs, which lead to the essentiality of the concept of glocalization. Although, the pandemic is global phenomenon, but the ideal approach and application is glocalized in nature. Nigeria nation adopts different measures to cushion the effect of the pandemic in accordance with WHO guidelines. The paper looks at the Nigerian experience and peculiarities as regards to the global standard. Primary and secondary source of data were utilized. The paper reveals some peculiarities in Nigerian localities in respect to face masking, lockdown order, hand washing, social distancing, palliative measures and other local innovations. The paper concluded that though, the vaccine for the pandemic has been detected globally but it has not been administered in Nigeria as of now, the citizens must continue to obey the WHO guidelines as they embrace the peculiarities of their local need

Gaseous Emission from the Combustion of Premium Motor Spirit (PMS) from the Kaduna Refinery and Petrochemical Company (KRPC) in Nigeria

Objectives : This study characterizes the gaseous emission from the combustion of PMS of different volumes from Kaduna Refinery and Petrochemical Company. Methods : The E8500 plus combustion analyzer was used for gaseous emission characterization of different volumes. Oxygen (O2), Hydrocarbons (HC), carbon monoxide (CO), carbon dioxide (CO2), Oxides of Nitrogen NOx (NO, NO2), Sulphur dioxide (SO2), and Hydrogen Sulfide (H2S) were measured using the analyzer. The values were recorded and the descriptive statistics graph was plotted. Results and Discussion : The concentrations for the gaseous emission from the combustion of PMS were 69.85 mg/m3 HC, 117.33 mg/m3 CO, 334 mg/m3 NOx for 10 ml, 58.93 mg/m3 HC, 130.33 mg/m3 CO, 784.33 mg/m3 NOx for 20 ml, 50.20 mg/m3 HC, 84.00 mg/m3 CO, 798.67 mg/m3 NOx for 30 ml, 65.48 mg/m3 HC, 160.33 mg/m3 CO, 850.33 mg/m3 NOx for 40 ml, 87.31 mg/m3 HC, 212.67 mg/m3 CO, 801.33 mg/m3 NOx, 3.67 mg/m3 SO2 for 50 ml. This study shows that CO and HC exceeded the permissible limit for stationary sources while NOx and SO2 were below the permissible limit. Conclusions : Hence, there is a need for rapid response and urgent attention from government and regulatory bodies to develop and implement appropriate policies that will help in reducing the effect. Appropriate measures to control air emissions that may be embarked upon by regulatory bodies include increase in the use of low-emission fuels and renewable fuels such as bio-fuels and introduction of the use of devices with low CO emissions

The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance

INTRODUCTION Investment in Africa over the past year with regard to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequencing has led to a massive increase in the number of sequences, which, to date, exceeds 100,000 sequences generated to track the pandemic on the continent. These sequences have profoundly affected how public health officials in Africa have navigated the COVID-19 pandemic. RATIONALE We demonstrate how the first 100,000 SARS-CoV-2 sequences from Africa have helped monitor the epidemic on the continent, how genomic surveillance expanded over the course of the pandemic, and how we adapted our sequencing methods to deal with an evolving virus. Finally, we also examine how viral lineages have spread across the continent in a phylogeographic framework to gain insights into the underlying temporal and spatial transmission dynamics for several variants of concern (VOCs). RESULTS Our results indicate that the number of countries in Africa that can sequence the virus within their own borders is growing and that this is coupled with a shorter turnaround time from the time of sampling to sequence submission. Ongoing evolution necessitated the continual updating of primer sets, and, as a result, eight primer sets were designed in tandem with viral evolution and used to ensure effective sequencing of the virus. The pandemic unfolded through multiple waves of infection that were each driven by distinct genetic lineages, with B.1-like ancestral strains associated with the first pandemic wave of infections in 2020. Successive waves on the continent were fueled by different VOCs, with Alpha and Beta cocirculating in distinct spatial patterns during the second wave and Delta and Omicron affecting the whole continent during the third and fourth waves, respectively. Phylogeographic reconstruction points toward distinct differences in viral importation and exportation patterns associated with the Alpha, Beta, Delta, and Omicron variants and subvariants, when considering both Africa versus the rest of the world and viral dissemination within the continent. Our epidemiological and phylogenetic inferences therefore underscore the heterogeneous nature of the pandemic on the continent and highlight key insights and challenges, for instance, recognizing the limitations of low testing proportions. We also highlight the early warning capacity that genomic surveillance in Africa has had for the rest of the world with the detection of new lineages and variants, the most recent being the characterization of various Omicron subvariants. CONCLUSION Sustained investment for diagnostics and genomic surveillance in Africa is needed as the virus continues to evolve. This is important not only to help combat SARS-CoV-2 on the continent but also because it can be used as a platform to help address the many emerging and reemerging infectious disease threats in Africa. In particular, capacity building for local sequencing within countries or within the continent should be prioritized because this is generally associated with shorter turnaround times, providing the most benefit to local public health authorities tasked with pandemic response and mitigation and allowing for the fastest reaction to localized outbreaks. These investments are crucial for pandemic preparedness and response and will serve the health of the continent well into the 21st century

Experience of quality management system in a clinical laboratory in Nigeria

Issues: Quality-management systems (QMS) are uncommon in clinical laboratories in Nigeria, and until recently, none of the nation’s 5 349 clinical laboratories have been able to attain the certifications necessary to begin the process of attaining international accreditation. Nigeria’s Human Virology Laboratory (HVL), however, began implementation of a QMS in 2006, and in 2008 it was determined that the laboratory conformed to the requirements of ISO 9001:2000 (now 2008), making it the first diagnostic laboratory to be certified in Nigeria. The HVL has now applied for the World Health Organization (WHO) accreditation preparedness scheme. The experience of the QMS implementation process and the lessons learned therein are shared here. Description: In 2005, two personnel from the HVL spent time studying quality systems in a certified clinical laboratory in Dakar, Senegal. Following this peer-to-peer technical assistance, several training sessions were undertaken by HVL staff, a baseline assessment was conducted, and processes were established. The HVL has monitored its quality indicators and conducted internal and external audits; these analyses (from 2007 to 2009) are presented herein. Lessons learned: Although there was improvement in the pre-analytical and analytical indicators analysed and although data-entry errors decreased in the post-analytical process, the delay in returning laboratory test results increased significantly. There were several factors identified as causes for this delay and all of these have now been addressed except for an identified need for automation of some high-volume assays (currently being negotiated). Internal and external audits showed a trend of increasing non-conformities which could be the result of personnel simply becoming lax over time. Application for laboratory accreditation, however, could provide the renewed vigour needed to correct these non-conformities. Recommendation: This experience shows that sustainability of the QMS at present is a cause for concern. However, the tiered system of accreditation being developed by WHO–Afro may act as a driving force to preserve the spirit of continual improvement

Full length genomic sanger sequencing and phylogenetic analysis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Nigeria.

In an outbreak, effective detection of the aetiological agent(s) involved using molecular techniques is key to efficient diagnosis, early prevention and management of the spread. However, sequencing is necessary for mutation monitoring and tracking of clusters of transmission, development of diagnostics and for vaccines and drug development. Many sequencing methods are fast evolving to reduce test turn-around-time and to increase through-put compared to Sanger sequencing method; however, Sanger sequencing remains the gold standard for clinical research sequencing with its 99.99% accuracy This study sought to generate sequence data of SARS-CoV-2 using Sanger sequencing method and to characterize them for possible site(s) of mutations. About 30 pairs of primers were designed, synthesized, and optimized using endpoint PCR to generate amplicons for the full length of the virus. Cycle sequencing using BigDye Terminator v.3.1 and capillary gel electrophoresis on ABI 3130xl genetic analyser were performed according to the manufacturers' instructions. The sequence data generated were assembled and analysed for variations using DNASTAR Lasergene 17 SeqMan Ultra. Total length of 29,760bp of SARS-CoV-2 was assembled from the sample analysed and deposited in GenBank with accession number: MT576584. Blast result of the sequence assembly shows a 99.97% identity with the reference sequence. Variations were noticed at positions: nt201, nt2997, nt14368, nt16535, nt20334, and nt28841-28843, which caused amino acid alterations at the S (aa614) and N (aa203-204) regions. The mutations observed at S and N-gene in this study may be indicative of a gradual changes in the genetic coding of the virus hence, the need for active surveillance of the viral genome